AVXL

Anavex Life Sciences Corp (AVXL)

US
$ 8.951.24%

Price Chart

Key Statistics

Market Cap
$ 714.56M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
349.93K
52W High
$ 14.44
52W Low
$ 3.51
Dividend Yield
0.00%
Beta
0.82

Technicals

50-Day MA
8.9266
200-Day MA
7.9893
52 Week High
14.4405
52 Week Low
3.51

About AVXL

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

Employees
42
Headquarters
New York, NY
CEO
Dr. Christopher U. Missling M.B.A., M.S., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg